924 related articles for article (PubMed ID: 19656901)
21. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
[TBL] [Abstract][Full Text] [Related]
22. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling.
Sato S; Sugiyama M; Yamamoto M; Watanabe Y; Kawai T; Takeda K; Akira S
J Immunol; 2003 Oct; 171(8):4304-10. PubMed ID: 14530355
[TBL] [Abstract][Full Text] [Related]
23. Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-beta-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IkappaB kinase gamma and increases A20 expression.
Xiong Y; Qiu F; Piao W; Song C; Wahl LM; Medvedev AE
J Biol Chem; 2011 Mar; 286(10):7905-7916. PubMed ID: 21220427
[TBL] [Abstract][Full Text] [Related]
24. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
[TBL] [Abstract][Full Text] [Related]
25. A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling.
Nilsen NJ; Vladimer GI; Stenvik J; Orning MP; Zeid-Kilani MV; Bugge M; Bergstroem B; Conlon J; Husebye H; Hise AG; Fitzgerald KA; Espevik T; Lien E
J Biol Chem; 2015 Feb; 290(6):3209-22. PubMed ID: 25505250
[TBL] [Abstract][Full Text] [Related]
26. Delineation of the role of Toll-like receptor signaling during peritonitis by a gradually growing pathogenic Escherichia coli.
van 't Veer C; van den Pangaart PS; Kruijswijk D; Florquin S; de Vos AF; van der Poll T
J Biol Chem; 2011 Oct; 286(42):36603-18. PubMed ID: 21690093
[TBL] [Abstract][Full Text] [Related]
27. Regulator of calcineurin 1 differentially regulates TLR-dependent MyD88 and TRIF signaling pathways.
Pang Z; Junkins RD; Raudonis R; MacNeil AJ; McCormick C; Cheng Z; Lin TJ
PLoS One; 2018; 13(5):e0197491. PubMed ID: 29799862
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of TLR4-induced IκB kinase activity by the RON receptor tyrosine kinase and its ligand, macrophage-stimulating protein.
Ray M; Yu S; Sharda DR; Wilson CB; Liu Q; Kaushal N; Prabhu KS; Hankey PA
J Immunol; 2010 Dec; 185(12):7309-16. PubMed ID: 21078906
[TBL] [Abstract][Full Text] [Related]
29. Dual regulation of osteopontin production by TLR stimulation in dendritic cells.
Salvi V; Scutera S; Rossi S; Zucca M; Alessandria M; Greco D; Bosisio D; Sozzani S; Musso T
J Leukoc Biol; 2013 Jul; 94(1):147-58. PubMed ID: 23610145
[TBL] [Abstract][Full Text] [Related]
30. LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury.
Vartanian KB; Stevens SL; Marsh BJ; Williams-Karnesky R; Lessov NS; Stenzel-Poore MP
J Neuroinflammation; 2011 Oct; 8():140. PubMed ID: 21999375
[TBL] [Abstract][Full Text] [Related]
31. The mechanism of LPS-induced HIV type I activation in transgenic mouse macrophages.
Kadoki M; Choi BI; Iwakura Y
Int Immunol; 2010 Jun; 22(6):469-78. PubMed ID: 20504885
[TBL] [Abstract][Full Text] [Related]
32. AKT1 distinctively suppresses MyD88-depenedent and TRIF-dependent Toll-like receptor signaling in a kinase activity-independent manner.
Zenke K; Muroi M; Tanamoto KI
Cell Signal; 2018 Mar; 43():32-39. PubMed ID: 29242168
[TBL] [Abstract][Full Text] [Related]
33. Sterile-α- and armadillo motif-containing protein inhibits the TRIF-dependent downregulation of signal regulatory protein α to interfere with intracellular bacterial elimination in Burkholderia pseudomallei-infected mouse macrophages.
Baral P; Utaisincharoen P
Infect Immun; 2013 Sep; 81(9):3463-71. PubMed ID: 23836818
[TBL] [Abstract][Full Text] [Related]
34. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
Carty M; Goodbody R; Schröder M; Stack J; Moynagh PN; Bowie AG
Nat Immunol; 2006 Oct; 7(10):1074-81. PubMed ID: 16964262
[TBL] [Abstract][Full Text] [Related]
35. Lysosome-associated small Rab GTPase Rab7b negatively regulates TLR4 signaling in macrophages by promoting lysosomal degradation of TLR4.
Wang Y; Chen T; Han C; He D; Liu H; An H; Cai Z; Cao X
Blood; 2007 Aug; 110(3):962-71. PubMed ID: 17395780
[TBL] [Abstract][Full Text] [Related]
36. Role of Adaptor Protein Toll-Like Interleukin Domain Containing Adaptor Inducing Interferon β in Toll-Like Receptor 3- and 4-Mediated Regulation of Hepatic Drug Metabolizing Enzyme and Transporter Genes.
Shah P; Omoluabi O; Moorthy B; Ghose R
Drug Metab Dispos; 2016 Jan; 44(1):61-7. PubMed ID: 26470915
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of anti-inflammatory effect of tricin, a flavonoid isolated from Njavara rice bran in LPS induced hPBMCs and carrageenan induced rats.
Shalini V; Jayalekshmi A; Helen A
Mol Immunol; 2015 Aug; 66(2):229-39. PubMed ID: 25839778
[TBL] [Abstract][Full Text] [Related]
38. Differential regulation of TLR-dependent MyD88 and TRIF signaling pathways by free zinc ions.
Brieger A; Rink L; Haase H
J Immunol; 2013 Aug; 191(4):1808-17. PubMed ID: 23863901
[TBL] [Abstract][Full Text] [Related]
39. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.
Dobrovolskaia MA; Medvedev AE; Thomas KE; Cuesta N; Toshchakov V; Ren T; Cody MJ; Michalek SM; Rice NR; Vogel SN
J Immunol; 2003 Jan; 170(1):508-19. PubMed ID: 12496438
[TBL] [Abstract][Full Text] [Related]
40. Cutting Edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation.
Sasai M; Oshiumi H; Matsumoto M; Inoue N; Fujita F; Nakanishi M; Seya T
J Immunol; 2005 Jan; 174(1):27-30. PubMed ID: 15611223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]